Scientific article

Allergologie : ce qui a changé en 2022

Published inRevue médicale suisse, vol. 19, no. 812, p. 196-198
Publication date2023-02-01

The study of reactions to SARS-CoV-2 vaccines has marked a large part of the literature in the last two years, using the basophil activation test (BAT) as a potential diagnostic tool for reactions to Covid-19 vaccines. In allergic rhinoconjunctivitis, lirentelimab (a humanised monoclonal antibody against lectin 8), reduces patients' symptoms and atopic comorbidities. In severe asthma, tezepelumab (human monoclonal antibody) reduces the annual asthma exacerbation rate over 52 weeks. In terms of diet, the new EAACI guidelines recommend avoiding cow's milk supplementation in infants during the first three days of life to reduce the risk of cow's milk allergy.

  • Infant
  • Animals
  • Cattle
  • Female
  • Humans
  • COVID-19 Vaccines
  • COVID-19 / epidemiology
  • COVID-19 / prevention & control
  • SARS-CoV-2
  • Milk Hypersensitivity / diagnosis
  • Asthma
Citation (ISO format)
PÉREZ CODESIDO, Sabela et al. Allergologie : ce qui a changé en 2022. In: Revue médicale suisse, 2023, vol. 19, n° 812, p. 196–198. doi: 10.53738/REVMED.2023.19.812.196
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 08/02/2024
ISSN of the journal1660-9379

Technical informations

Creation10/05/2023 1:30:55 PM
First validation02/21/2024 9:17:32 AM
Update time02/21/2024 9:17:32 AM
Status update02/21/2024 9:17:32 AM
Last indexation02/21/2024 9:17:53 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack